Cargando…
Molybdenum Cofactor Deficiency in Humans
Molybdenum cofactor (Moco) deficiency (MoCD) is characterized by neonatal-onset myoclonic epileptic encephalopathy and dystonia with cerebral MRI changes similar to hypoxic–ischemic lesions. The molecular cause of the disease is the loss of sulfite oxidase (SOX) activity, one of four Moco-dependent...
Autores principales: | Johannes, Lena, Fu, Chun-Yu, Schwarz, Günter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607355/ https://www.ncbi.nlm.nih.gov/pubmed/36296488 http://dx.doi.org/10.3390/molecules27206896 |
Ejemplares similares
-
Protein-bound molybdenum cofactor is bioavailable and rescues molybdenum cofactor-deficient C. elegans
por: Warnhoff, Kurt, et al.
Publicado: (2021) -
Sulfite Alters the Mitochondrial Network in Molybdenum Cofactor Deficiency
por: Mellis, Anna-Theresa, et al.
Publicado: (2021) -
Molybdenum cofactor deficiency: Neuroimaging findings
por: Durmaz, Mehmet Sedat, et al.
Publicado: (2018) -
Molybdenum cofactor deficiency: A natural history
por: Spiegel, Ronen, et al.
Publicado: (2022) -
Investigation of molybdenum cofactor deficiency due to MOCS2 deficiency in a newborn baby
por: Edwards, Matthew, et al.
Publicado: (2015)